Press Releases

Name: Medicure Inc.
Address: 1250 Waverley Street, Winnipeg, Manitoba, R3T 6C6
Price range: unknown

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016 April 26, 2017	Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017 March 29, 2017	Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine March 23, 2017
Medicure Provides Apicore Secured Loan to Replace Knight Loan January 9, 2017	Medicure announces filing of ANDA in collaboration with Apicore December 13, 2016	Medicure Closes Acquisition of Majority Interest in Apicore December 1, 2016
Medicure to Hold Investor Call on November 21, 2016 November 18, 2016	Medicure Exercises Option to Acquire Majority Interest in Apicore November 18, 2016	Medicure Reports Third Quarter 2016 Financial Results November 9, 2016
Medicure to Announce Q3 2016 Financial Results on November 9, 2016 November 2, 2016	FDA Approves New AGGRASTAT® Product Format September 1, 2016	Medicure Reports Second Quarter 2016 Financial Results August 10, 2016
Medicure to Announce Q2 2016 Financial Results on August 10, 2016 August 3, 2016	Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication July 7, 2016	Medicure Reports First Quarter 2016 Financial Results May 11, 2016
Medicure Files Application for New AGGRASTAT® Product Format May 11, 2016	Medicure Announces Departure of President and Chief Operating Officer May 9, 2016	Medicure to Announce Q1 2016 Financial Results on May 11, 2016 May 4, 2016
Medicure Announces Grant of Options April 7, 2016	Medicure Announces Upcoming Conference Presentations April 5, 2016	Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015 March 30, 2016
Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016 March 23, 2016	Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference February 23, 2016	Medicure to present at Cantech Investment Conference January 21, 2016
Medicure Announces Preliminary Revenue For Fiscal 2015 January 11, 2016	Medicure announces ANDA collaboration with Apicore January 6, 2016	Medicure Announces PDUFA Action Date for New Aggrastat Indication December 2, 2015
Medicure Announces Grant of Stock Options November 25, 2015	Medicure Reports Third Quarter 2015 Financial Results November 9, 2015	Medicure Q3 Results and Conference Call Dates November 3, 2015
Medicure Announces Filing of sNDA for New AGGRASTAT® Indication September 10, 2015	Medicure Reports Second Quarter 2015 Financial Results August 11, 2015	Medicure Q2 Results And Conference Call Dates August 5, 2015
Medicure Announces Grant Of Options July 7, 2015	Medicure Closes Bought Deal Private Placement Financing for Gross Proceeds of $4,025,000 June 26, 2015	Medicure Announces $3.5 Million "Bought Deal" Private Placement June 10, 2015
Medicure Reports Financial Results for the First Quarter of 2015 April 29, 2015	Medicure Q1 Results and Conference Call Dates April 27, 2015	Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT® April 23, 2015
Medicure to present at the 2015 Bloom Burton & Co. Healthcare Conference April 22, 2015	Medicure reports financial results for the seven months ended December 31, 2014 April 14, 2015	Medicure announces grant of options March 27, 2015
Medicure announces issuance of shares under previously announced shares for debt settlement March 20, 2015	Medicure provides quarterly revenue on a calendar basis following change to year end February 2, 2015	Medicure announces shares for debt settlements January 27, 2015
Medicure announces issuance of shares under previously announced shares for debt settlement January 9, 2015	Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue December 18, 2014	Dr. Albert D. Friesen to File Early Warning Report November 5, 2014
Medicure Reports Financial Results for the First Quarter Fiscal 2015 October 16, 2014	Medicure Reports Financial Results for Fiscal 2014 September 10, 2014	Medicure Provides Update on Tardoxal and TEND-TD Study August 13, 2014
Medicure Announces Shares for Debt Settlement July 11, 2014	Medicure Announces Grant of Options July 7, 2014	Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore July 3, 2014
Medicure Comments on Recent Trading Activity April 15, 2014	Medicure Engages Knight Therapeutics Inc. to Provide Advisory Services April 14, 2014	Medicure Reports Financial Results for the Third Quarter Fiscal 2014 March 26, 2014
Medicure Reports Second Quarter Financial Results for Fiscal 2014 January 28, 2014	Medicure Reports First Quarter Financial Results for Fiscal 2014 October 30, 2013	Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT® October 11, 2013

Newer | Older

Press Releases

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016

Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017

Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine

Medicure Provides Apicore Secured Loan to Replace Knight Loan

Medicure announces filing of ANDA in collaboration with Apicore

Medicure Closes Acquisition of Majority Interest in Apicore

Medicure to Hold Investor Call on November 21, 2016

Medicure Exercises Option to Acquire Majority Interest in Apicore

Medicure Reports Third Quarter 2016 Financial Results

Medicure to Announce Q3 2016 Financial Results on November 9, 2016

FDA Approves New AGGRASTAT® Product Format

Medicure Reports Second Quarter 2016 Financial Results

Medicure to Announce Q2 2016 Financial Results on August 10, 2016

Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication

Medicure Reports First Quarter 2016 Financial Results

Medicure Files Application for New AGGRASTAT® Product Format

Medicure Announces Departure of President and Chief Operating Officer

Medicure to Announce Q1 2016 Financial Results on May 11, 2016

Medicure Announces Grant of Options

Medicure Announces Upcoming Conference Presentations

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015

Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

Medicure to present at Cantech Investment Conference

Medicure Announces Preliminary Revenue For Fiscal 2015

Medicure announces ANDA collaboration with Apicore

Medicure Announces PDUFA Action Date for New Aggrastat Indication

Medicure Announces Grant of Stock Options

Medicure Reports Third Quarter 2015 Financial Results

Medicure Q3 Results and Conference Call Dates

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

Medicure Reports Second Quarter 2015 Financial Results

Medicure Q2 Results And Conference Call Dates

Medicure Announces Grant Of Options

Medicure Closes Bought Deal Private Placement Financing for Gross Proceeds of $4,025,000

Medicure Announces $3.5 Million "Bought Deal" Private Placement

Medicure Reports Financial Results for the First Quarter of 2015

Medicure Q1 Results and Conference Call Dates

Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT®

Medicure to present at the 2015 Bloom Burton & Co. Healthcare Conference

Medicure reports financial results for the seven months ended December 31, 2014

Medicure announces grant of options

Medicure announces issuance of shares under previously announced shares for debt settlement

Medicure provides quarterly revenue on a calendar basis following change to year end

Medicure announces shares for debt settlements

Medicure announces issuance of shares under previously announced shares for debt settlement

Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue

Dr. Albert D. Friesen to File Early Warning Report

Medicure Reports Financial Results for the First Quarter Fiscal 2015

Medicure Reports Financial Results for Fiscal 2014

Medicure Provides Update on Tardoxal and TEND-TD Study

Medicure Announces Shares for Debt Settlement

Medicure Announces Grant of Options

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore

Medicure Comments on Recent Trading Activity

Medicure Engages Knight Therapeutics Inc. to Provide Advisory Services

Medicure Reports Financial Results for the Third Quarter Fiscal 2014

Medicure Reports Second Quarter Financial Results for Fiscal 2014

Medicure Reports First Quarter Financial Results for Fiscal 2014

Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT®

Stay Connected

Sign up for our newsletter

About

Products

News and Media

Investors

Online Pharmacy

Contact Us